日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Liver Stiffness Rises Early in MASLD and Drives Inflammation, Lipid Dysmetabolism, and Fibrosis via Piezo1-YAP Mechanotransduction

在MASLD早期,肝脏硬度升高,并通过Piezo1-YAP机械转导途径驱动炎症、脂质代谢紊乱和纤维化。

Ma, Juan; Xie, Ning; Wang, Ziwei; Liang, Xiru; Han, Yulong; Zhao, Qiang; Wang, Ming; Lu, Hongwei; Kou, Wanyi; Alazawi, William; Wang, Jinhai; Li, Lu; Liu, Ning; Liu, Na; Shi, Haitao; Xu, Feng

Doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis-leave no one behind: author's reply

将高危代谢功能障碍相关脂肪性肝炎的诊断率提高一倍——不让任何人掉队:作者回复

Lazarus, Jeffrey V; Alazawi, William; Byrne, Christopher D; Caussy, Cyrielle; Brennan, Paul N

Real-world evidence in metabolic dysfunction-associated steatotic liver disease (MASLD): insights, challenges, and future directions

代谢功能障碍相关脂肪肝病(MASLD)的真实世界证据:见解、挑战和未来方向

Huang, Huei-Tyng; Hewitt, Michael; Li, Wenhao; Alazawi, William

High inherited risk predicts age-associated increases in fibrosis in patients with MASLD

高遗传风险预示着MASLD患者随着年龄增长纤维化程度会加重。

Díaz, Luis Antonio; Alazawi, William; Agrawal, Saaket; Arab, Juan Pablo; Arrese, Marco; Idalsoaga, Francisco; Barreyro, Fernando Javier; Gadano, Adrian; Marciano, Sebastián; Martínez Morales, Jorge; Villela-Nogueira, Cristiane; Leite, Nathalie; Couto, Claudia Alves; Theodoro, Rafael; Monteiro, Mísia Joyner de Sousa Dias; Oliveira, Claudia P; Pessoa, Mario G; Alvares-da-Silva, Mario Reis; Madamba, Egbert; Bettencourt, Ricki; Richards, Lisa M; Majithia, Amit R; Khera, Amit V; Loomba, Rohit; Ajmera, Veeral

A call for doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis

呼吁将高危代谢功能障碍相关脂肪性肝炎的诊断率提高一倍

Lazarus, Jeffrey V; Brennan, Paul N; Mark, Henry E; Alazawi, William; Allen, Alina M; Byrne, Christopher D; Castera, Laurent; Caussy, Cyrielle; Cusi, Kenneth; Grajower, Martin M; Kopka, Christopher J; Massoels, Jo; Roden, Michael; Spearman, C Wendy; Tacke, Frank; Wong, Vincent Wai-Sun; Noureddin, Mazen

Current Surveillance Strategy Is Less Effective for Detecting Early-Stage Hepatocellular Carcinoma in Patients with Non-Viral and Non-Cirrhotic Liver Disease

目前的监测策略对于非病毒性和非肝硬化性肝病患者早期肝细胞癌的检出效果较差。

Spiers, Jessica; Li, Wenhao; Aravinthan, Aloysious D; Bannaga, Ayman; Caddick, Katharine; Culver, Emma L; Faulkes, Rosemary E; Gordon, Victoria; Hussain, Yaqza; Miller, Hamish; Merry, Jenny; Saad, Muhammad; Sheth, Abhishek; Shah, Tahir; Shetty, Shishir; Srivastava, Ankur; Subhani, Mohsan; Tahir, Muhammad Nauman; Than, Nwe Ni; Unitt, Esther; Alazawi, William

A European Survey to Identify Challenges in the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease

一项旨在识别代谢功能障碍相关脂肪肝疾病管理挑战的欧洲调查

Castera, Laurent; Alazawi, William; Bugianesi, Elisabetta; Caussy, Cyrielle; Federici, Massimo; Romero-Gómez, Manuel; Schattenberg, Jörn M; Basuroy, Ron; Prasad, Preethy; Estulin, Dmitry; Lazarus, Jeffrey V

Metabolic dysfunction-associated steatotic liver disease

代谢功能障碍相关性脂肪肝

Hsu, Catherine; Alazawi, William

Endogenous C-type natriuretic peptide offsets the pathogenesis of steatohepatitis, hepatic fibrosis, and portal hypertension

内源性C型钠尿肽可抵消脂肪性肝炎、肝纤维化和门静脉高压的发病机制。

Perez-Ternero, Cristina; Li, Wenhao; Aubdool, Aisah A; Goldin, Robert D; Loy, John; Devalia, Kalpana; Alazawi, William; Hobbs, Adrian J

Epidemiology of Metabolic Dysfunction-Associated Steatotic Liver Disease in South Asian Ethnicities: A Systematic Review and Meta-Analysis

南亚人群代谢功能障碍相关脂肪肝疾病的流行病学:系统评价和荟萃分析

James, Michael; Smuk, Melanie; Rahman, Naheeda; Black, Georgia; Alazawi, William